Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | GRI Bio, Inc. GRI | Altium Capital Management LLC | 97,632 4.990% | 83,684 (+600.00%) | Filing History |
| 2023-05-02 8:23 pm Purchase | 2023-04-24 | 13G | GRI Bio, Inc. GRI | Altium Capital Management LLC | 13,947 9.990% | 13,947 (New Position) | Filing History |
| 2023-05-02 4:05 pm Purchase | 2023-04-21 | 13G | GRI Bio, Inc. GRI | TEP Biotech LLC | 2,252 6.930% | 2,252 (New Position) | Filing History |
| 2023-04-25 4:19 pm Purchase | 2023-04-21 | 13D | GRI Bio, Inc. GRI | Chaturvedi Vipin | 1,892 5.820% | 1,892 (New Position) | Filing History |
| 2023-04-25 4:19 pm Purchase | 2023-04-21 | 13D | GRI Bio, Inc. GRI | Agro Albert | 1,892 5.820% | 1,892 (New Position) | Filing History |
| 2023-04-25 4:18 pm Purchase | 2023-04-21 | 13D | GRI Bio, Inc. GRI | Hertz Walter Marc | 4,236 13.040% | 4,236 (New Position) | Filing History |
| 2023-02-13 4:30 pm Sale | 2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lind Global Fund II LP | 250 0.100% | -35,900 (-99.31%) | Filing History |
| 2023-01-30 09:09 am Sale | 2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | BIGGER CAPITAL FUND L P | 0 0.000% | -24,667 (Position Closed) | Filing History |
| 2022-12-27 11:09 am Sale | 2022-12-14 | 13G | Vallon Pharmaceuticals, Inc. VLON | Markey John | 0 0.000% | -28,316 (Position Closed) | Filing History |
| 2022-09-28 5:47 pm Purchase | 2022-09-28 | 13G | Vallon Pharmaceuticals, Inc. VLON | Markey John | 28,316 8.100% | 28,316 (New Position) | Filing History |
| 2022-05-23 5:00 pm Purchase | 2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lind Global Fund II LP | 36,150 9.900% | 36,150 (New Position) | Filing History |
| 2022-05-23 4:30 pm Purchase | 2022-05-13 | 13G | Vallon Pharmaceuticals, Inc. VLON | BIGGER CAPITAL FUND L P | 24,667 5.300% | 24,667 (New Position) | Filing History |
| 2022-05-18 12:34 pm Purchase | 2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lincoln Park Capital Fund LLC | 35,008 9.990% | 35,008 (New Position) | Filing History |
| 2022-02-17 3:29 pm Purchase | 2021-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | Malnik Dov | 16,993 7.500% | 16,993 (New Position) | Filing History |
| 2022-02-14 9:41 pm Purchase | 2021-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | Arcturus Therapeutics Holdings Inc. ARCT | 28,125 12.380% | 28,125 (New Position) | Filing History |
| 2021-03-15 7:51 pm Unchanged | 2021-02-09 | 13D | Vallon Pharmaceuticals, Inc. VLON | SALMON Pharma GmbH | 50,793 22.400% | 0 (Unchanged) | Filing History |
| 2021-02-12 6:02 pm Purchase | 2021-02-09 | 13D | Vallon Pharmaceuticals, Inc. VLON | SALMON Pharma GmbH | 50,793 20.500% | 50,793 (New Position) | Filing History |